 |  |
| ABX | ||
| 2,547.709 | ||
| 38.1650 | 0.0152% | |
| BISNIS-27 | ||
| 552.102 | ||
| 1.4280 | 0.0026% | |
| DBX | ||
| 4,207.954 | ||
| 38.0540 | 0.0091% | |
| ECONOMIC30 | ||
| 115.995 | ||
| 0.0690 | 0.0006% | |
| ESGQKEHATI | ||
| 127.617 | ||
| 0.2440 | 0.0019% | |
| ESGSKEHATI | ||
| 128.289 | ||
| 0.4870 | 0.0038% | |
| I-GRADE | ||
| 232.381 | ||
| 1.1900 | 0.0051% | |
| AUDRP | ||
| 11,086.180 | ||
| 37.2300 | 0.3370% | |
| EURRP | ||
| 19,445.290 | ||
| 68.1100 | 0.3515% | |
| JPYRP | ||
| 107.596 | ||
| 0.4509 | 0.4208% | |
| SINRP | ||
| 12,879.970 | ||
| 43.5400 | 0.3392% | |
| USDRP | ||
| 16,686.000 | ||
| 41.0000 | 0.2463% | |
Sejumlah lembaga asal Indonesia bekerja sama dengan perusahaan farmasi luar negeri dalam mengembangkan produksi vaksin COVID-19 di dalam negeri. Badan Pengawas Obat dan Makanan (BPOM) mencatat setidaknya terdapat lima pengembangan kandidat vaksin COVID-19 yang cukup menjanjikan.
